Seattle / Rockville / Washington / DC / College Station / Ingelheim / /
Company
Boehringer Ingelheim Pharmaceuticals Inc / StataCorp LP / AHR / Wilson / Agency for Healthcare Research / BioMed Central Ltd. / Creative Commons / /
Country
Germany / United States / /
Currency
USD / / /
EntertainmentAwardEvent
the National Institutes of Health under Award / /
Facility
Blood Institute / University of Texas Southwestern Medical Center / University of Washington / /
IndustryTerm
cardiovascular disease prevention / health services / prediction tool / prevention of cardiovascular disease / statistical software / prevention of vascular disease / prevention of cancers / /
MedicalCondition
vascular disease / DF / atherosclerotic vascular disease / strokes / atherothrombotic disease / actual Roth et al. BMC Cardiovascular Disorders / sex Male Female Total No disease / ischemic heart disease / heart disease / heart attacks / common chronic diseases / angina / coronary heart disease / No disease / MS / BMC Cardiovascular Disorders / chronic conditions / cancers / et al. BMC Cardiovascular Disorders / atherosclerotic cerebrovascular and coronary artery disease / hypertension / cancer / CHD / disease / atherosclerosis / cerebral infarction / calculated coronary heart disease / stroke / diabetes / cardiovascular disease / Allergy / pain / established disease / myocardial infarction / heart attack / chronic disease / diseases / coronary artery disease / chronic diseases / preselected common chronic conditions / /
MedicalTreatment
chemoprevention / Surgery / bypass / /
NaturalFeature
Ruffin MT / Cooney MT / /
Organization
University of Texas Southwestern Medical Center / Dallas / European association / Institute for Health Metrics and Evaluation / U.S. Preventive Services Task Force / National Center For Advancing Translational Sciences of the National Institutes of Health / Department of Medicine / Department of Pharmacy / Division of Cardiology / U.S. Census Bureau / the American college / National Heart / Lung / and Blood Institute of the National Institutes of Health / University of Washington / Seattle / Agency for Healthcare Research and Quality / /
Person
Linda Risler / Prince / Lawrence JR / Greg Roth / Arch Intern / Arch Fam Med / Ann Oncol / /
Position
author / Prince / King / Governor / Kannel WB / Fisher / representative / /
Product
dipyridamole / AGGRENOX / /
ProgrammingLanguage
DC / /
ProvinceOrState
Texas / Seattle-King County / King County / Maryland / /
Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)